Skip to main content

Table 1 Characteristics of included randomized trials

From: Effects of omega-3 fatty acids on patients undergoing surgery for gastrointestinal malignancy: a systematic review and meta-analysis

Trial(year)

Time

Country

Intervention

n-3 PUFA,n

Contro l, n

Age

BMI

Cancer

Studu design

Parameters

Ma et al. [12]

2015

China

0.8–1.5 g/kg/d LCT,MCT, n-3PUFA

44

41

61.55 ± 9.78

23.45 ± 3.44 44

stomach, colon

Randomized

IL-6, CRP, TNF-α

Ziran et al. [13]

2014

Brazil

104–125 kJ/kg/d EPA + DHA

26

20

36–74

17.8–29.7

stomach

Randomized

CD3, CD4, CD8, CD4/CD8, albumin, L-6, CRP, TNF-α

Liu et al. [14]

2009

China

83.68 kJ/kg/d n-3PUFA

22

20

64.02

Not Given

stomach, colon

Randomized

CD3, CD4, CD8, CD4/CD8, albumin, CRP

Hu et al. [15]

2015

China

104–125 kJ/kg/d n-3PUFA

44

44

23–78

Not Given

stomach, colon

Randomized

CD3, CD4, CD8, CD4/CD8, IL-6, CRP, TNF-α

Zheng et al. [16]

2011

China

25 kcal//kg/d n-3PUFA

20

20

56.19 ± 11.80

Not Given

colon, rectum

Randomized

CD3, CD4, CD4/CD8, albumin, CRP

ZHU et al. [17]

2012

China

1.2 g/kg/d n-3PUFA

29

28

70.8 ± 6.4

18.5–25.0

colon

Randomized

CD4, CD8, CD4/CD8, IL-6, TNF-α

Aoife et al. [18]

2009

Ireland

2.2 g/d EPA

28

25

62

24.6

esophagus

Randomized

albumin, IL-6

Huang et al. [19]

2014

China

25 kcal//kg/d n-3PUFA

40

40

60.88 ± 7.54

Not Given

esophagus

Randomized

CD3, CD4, CD8, CD4/CD8

Sultan et al. [20]

2012

UK

EPA 0·51 g/100 ml + DHA 0·22 g /100 ml

66

66

67 (42–79)

Not Given

esophagus, stomach

Randomized

CD3, CD4, CD8, CD4/CD8

  1. LCT long-chain triglyceride, MCT medium-chain triglyceride